Director, Market Insights & Forecasting

The Director, Market Insights & Analytics, U.S. Portfolio & Launch Readiness supports U.S. market insights, forecast transition, strategic planning, and launch-readiness analytics for assets approaching commercialization. The role serves as the U.S. commercial bridge between global early-stage forecasting and U.S. launch planning, ensuring assets within approximately two years of expected U.S. launch have clear, pressure-tested assumptions, planning timelines, market context, analytics requirements, and source-of-truth outputs. The Director reports into Market Insights & Forecasting and has dotted-line accountability to Analytics & Decision Support. This is an individual contributor role that leads through influence across global and U.S. stakeholders, with no direct people-management responsibility.

Responsibilities

Lead U.S. forecast transition and launch-readiness planning for assets approaching commercialization; Partner with global forecasting teams to understand early-stage forecast assumptions, market models, epidemiology, patient flow, competitive context, evidence expectations, and key uncertainties; Translate global forecast inputs into U.S.-specific commercial planning assumptions, including market size, patient opportunity, treatment flow, adoption drivers, access considerations, competitive dynamics, launch timing, and scenario ranges; Support the Senior Director, Market Insights & Forecasting in developing U.S. forecast assumptions, strategic planning inputs, scenario framing, launch-readiness narratives, risk and opportunity assessments, and senior leadership materials; Coordinate U.S. strategic planning timelines, deliverables, assumption-gathering processes, cross-functional inputs, review meetings, and consolidated planning materials for near-launch assets; Develop and maintain structured handoff processes between global early-stage forecasting and U.S. commercial planning to ensure clear ownership, assumption traceability, documentation, and decision rights; Partner with the Director, Analytics & Decision Support to develop launch-readiness dashboards, planning trackers, forecast comparison views, assumption logs, milestone trackers, and source-of-truth reporting outputs; Partner with Data/Technology, BIS, Finance, and analytics stakeholders to define reporting requirements, support automation of recurring launch-readiness views, integrate planning inputs, and create scalable reporting structures; Synthesize primary research, secondary data, competitive intelligence, global assumptions, market access inputs, Medical perspective, and U.S. commercial feedback into clear planning implications and recommended actions; Support executive-ready materials for strategic planning, launch planning, investment prioritization, forecast reviews, business updates, and cross-functional leadership discussions; Track key external and internal signals that may affect U.S. commercialization assumptions, including clinical readouts, regulatory milestones, guideline updates, competitive events, access dynamics, customer feedback, and market structure changes; Ensure launch-readiness forecasting, planning, and reporting activities comply with applicable privacy, legal, regulatory, procurement, finance, and pharmaceutical industry requirements

Requirements

Bachelor's degree in business, scientific, quantitative, technical, or related discipline required; 8 to 10+ years of pharmaceutical or biotechnology experience with expertise in forecasting, market insights, commercial analytics, strategic planning, launch planning, pipeline transition, or decision support; Demonstrated experience translating forecast assumptions, market research, competitive intelligence, clinical or regulatory milestones, and commercial inputs into clear business implications and planning recommendations; Strong understanding of pharmaceutical commercialization planning, including patient flow, epidemiology, market sizing, forecast assumptions, scenario planning, access considerations, competitive dynamics, and launch-readiness planning; Experience supporting strategic planning, long-range planning, launch planning, forecast reviews, or cross-functional commercial planning processes; Strong analytical capability, including experience with forecast models, dashboard requirements, data visualization, Excel, PowerPoint, and business intelligence tools such as Power BI; Experience and extensive knowledge of medical and pharmacy claims data and longitudinal patient data (e.g., IQVIA LAAD and NPA); Ability to partner across global and U.S. teams, clarify decision rights, document assumptions, manage planning timelines, and translate early forecast inputs into U.S. commercial planning outputs; Demonstrated ability to operate independently in ambiguous, cross-functional environments with multiple stakeholders, evolving timelines, and high senior-leadership visibility; Excellent communication, presentation, stakeholder management, and project leadership skills, with the ability to synthesize complex qualitative and quantitative information into clear recommendations

Nice to have

Advanced degree preferred; Experience with pharmaceutical data sources such as claims, specialty pharmacy data, syndicated data, market research outputs, patient-level or longitudinal data, internal finance or demand data, and public-company disclosures